GDC-4198

News alerts, weekly reports and conference planners

Company:

Regor, Roche

Drug class:

CDK4 inhibitor, CDK6 inhibitor, CDK2 inhibitor

Related drugs:

CCNE1 overexpression	Estrogen Receptor Positive Breast Cancer	CCNE1 overexpression	Estrogen Receptor Positive Breast Cancer	GDC-4198 Sensitive: D – Preclinical GDC-4198 Sensitive : D	GDC-4198 Sensitive: D – Preclinical GDC-4198 Sensitive : D
ER positive	Estrogen Receptor Positive Breast Cancer	ER positive	Estrogen Receptor Positive Breast Cancer	GDC-4198 Sensitive: D – Preclinical GDC-4198 Sensitive : D	GDC-4198 Sensitive: D – Preclinical GDC-4198 Sensitive : D

Associations
(2)